Hour-Specific Risk for Neonatal Hyperbilirubinemia

ورودی‌های بالینی بیمار

حداقل ۱۲ — حداکثر ۱۶۸ • واحد: hours

حداقل ۰.۱ — حداکثر ۳۰ • واحد: mg/dL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
risk zone
—zone
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–39
  • Low-Intermediate Risk40–75
  • High-Intermediate Risk76–94
  • High Risk95–100
Direct Clinical Answer

The Hour-Specific Risk for Neonatal Hyperbilirubinemia calculates predicting risk of hyperbilirubinemia in neonates based on total serum bilirubin measurement using the Bhutani nomogram. Key inputs include age hours. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Predicts risk of hyperbilirubinemia in neonates based on total serum bilirubin measurement using the Bhutani nomogram. Identifies infants at risk for subsequent significant hyperbilirubinemia.

Clinical Indication

The Hour-Specific Risk for Neonatal Hyperbilirubinemia is indicated for bedside clinical practice to support Predicts risk of hyperbilirubinemia in neonates based on total serum bilirubin measurement using the Bhutani nomogram. Identifies infants at risk for subsequent significant hyperbilirubinemia.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.

Limitations & Contraindications

Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.

Clinical Pearls & Action Plan

Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice. Guideline pearl: Recommended follow-up timing: Discharged <24 hrs see by 72 hrs, 24-48 hrs see by 96 hrs, 48-72 hrs see by 120 hrs.

Formula & Variables:

Risk zone based on hour-specific bilirubin percentiles from Bhutani nomogram

Input Parameters

NameTypeRequiredDescription
age_hoursintegerYesAge of neonate in hours (from birth)(hours)
total_bilirubinfloatYesTotal serum bilirubin level(mg/dL)

Score Interpretation & Guidance

RangeStageDescription
0–39Low Risk<40th percentile
40–75Low-Intermediate Risk40th-75th percentile
76–94High-Intermediate Risk76th-94th percentile
95–100High Risk≥95th percentile

Evidence-Based References (EBM)

  • Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999 Jan;103(1):6-14.
  • American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004 Jul;114(1):297-316.

Related calculators